Suchergebnisse - "Balar, Arjun V."

PubPharm (70)

1

A plain language summary of the TROPHY-U-01 study : sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer

enthalten in: Future oncology (London, England) | 2024

von Loriot, Y. | Kalebasty, A. | Fléchon, A. | +16

2

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

enthalten in: Prostate cancer and prostatic diseases | 2024

von Wise, D. | Pachynski, R. | Denmeade, S. | +29

3

Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile

enthalten in: The Prostate | 2023

von Adorno Febles, V. | Hao, Y. | Ahsan, A. | +19

4

Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma : Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial

enthalten in: The oncologist | 2023

von Larkin, J. | Oya, M. | Martignoni, M. | +16

5

Bempegaldesleukin plus Nivolumab in First-line Metastatic Urothelial Carcinoma : Results from PIVOT-02

enthalten in: European urology | 2022

von Siefker-Radtke, A. | Cho, D. | Diab, A. | +15

CommentIn: Eur Urol. 2022 Oct;82(4):374-376. - PMID 35752503

6

Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer : Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Bellmunt, J. | de Wit, R. | Fradet, Y. | +28

CommentIn: J Urol. 2023 May;209(5):1025-1026. - PMID 37026649

7

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer : A Multicenter, Single-Arm, Phase II Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Funt, S. | Lattanzi, M. | Whiting, K. | +36

CommentIn: J Clin Oncol. 2022 Aug 10;40(23):2656. - PMID 35609220

8

Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma : results from the PIVOT-02 study

enthalten in: Journal for immunotherapy of cancer | 2022

von Tannir, N. | Cho, D. | Diab, A. | +15

9

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

enthalten in: European urology open science | 2021

von Autio, K. | Antonarakis, E. | Mayer, T. | +24

10

Immune Checkpoint Inhibitors for Genitourinary Cancers : Treatment Indications, Investigational Approaches and Biomarkers

enthalten in: Cancers | 2021

von Labadie, B. | Balar, A. | Luke, J.

1
2
3
4
5
6
7
Nächster »
[7]